This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pan-Zhou, X.-R.
Right arrow Articles by Darley-Usmar, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan-Zhou, X.-R.
Right arrow Articles by Darley-Usmar, V. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2000, p. 496-503, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells

Xin-Ru Pan-Zhou,1 Lixin Cui,1 Xiao-Jian Zhou,1 Jean-Pierre Sommadossi,1,* and Victor M. Darley-Usmar2

Department of Clinical Pharmacology, Center for AIDS Research,1 and Department of Pathology, Center for Free Radical Biology,2 University of Alabama at Birmingham, Birmingham, Alabama 35294-0019

Received 10 June 1999/Returned for modification 20 September 1999/Accepted 29 November 1999

Numerous studies have reported effects of antiviral nucleoside analogs on mitochondrial function, but they have not correlated well with the observed toxic side effects. By comparing the effects of the five Food and Drug Administration-approved anti-human immunodeficiency virus nucleoside analogs, zidovudine (3'-azido-3'-deoxythymidine) (AZT), 2',3'-dideoxycytidine (ddC), 2',3'-dideoxyinosine (ddI), 2',3'-didehydro-2',3'-deoxythymidine (d4T), and beta -L-2',3'-dideoxy-3'-thiacytidine (3TC), as well as the metabolite of AZT, 3'-amino-3'-deoxythymidine (AMT), on mitochondrial function in a human hepatoma cell line, this issue has been reexamined. Evidence for a number of mitochondrial defects with AZT, ddC, and ddI was found, but only AZT induced a marked rise in lactic acid levels. Only in mitochondria isolated from AZT (50 µM)-treated cells was significant inhibition of cytochrome c oxidase and citrate synthase found. Our investigations also demonstrated that AZT, d4T, and 3TC did not affect the synthesis of the 11 polypeptides encoded by mitochondrial DNA, while ddC caused 70% reduction of total polypeptide content and ddI reduced by 43% the total content of 8 polypeptides (including NADH dehydrogenase subunits 1, 2, 4, and 5, cytochrome c oxidase subunits I to III, and cytochrome b). We hypothesize that in hepatocytes the reserve capacity for mitochondrial respiration is such that inhibition of respiratory enzymes is unlikely to become critical. In contrast, the combined inhibition of the citric acid cycle and electron transport greatly enhances the dependence of the cell on glycolysis and may explain why apparent mitochondrial dysfunction is more prevalent with AZT treatment.

* Corresponding author. Mailing address: University of Alabama at Birmingham/Box 600, Volker Hall GO19, University Station, Birmingham, AL 35294. Phone: (205) 934-8266. Fax: (205) 975-4871. E-mail: Jean-Pierre.Sommadossi{at}ccc.uab.edu.

Antimicrobial Agents and Chemotherapy, March 2000, p. 496-503, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Maagaard, A., Kvale, D. (2009). Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?. J Antimicrob Chemother 64: 901-909 [Abstract] [Full Text]  
  • Bridges, E. G., Selden, J. R., Luo, S. (2008). Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B. Antimicrob. Agents Chemother. 52: 2521-2528 [Abstract] [Full Text]  
  • Mazzucco, C. E., Hamatake, R. K., Colonno, R. J., Tenney, D. J. (2008). Entecavir for Treatment of Hepatitis B Virus Displays No In Vitro Mitochondrial Toxicity or DNA Polymerase Gamma Inhibition. Antimicrob. Agents Chemother. 52: 598-605 [Abstract] [Full Text]  
  • Xu, Y., Johansson, M., Karlsson, A. (2008). Human UMP-CMP Kinase 2, a Novel Nucleoside Monophosphate Kinase Localized in Mitochondria. J. Biol. Chem. 283: 1563-1571 [Abstract] [Full Text]  
  • Saitoh, A., Fenton, T., Alvero, C., Fletcher, C. V., Spector, S. A. (2007). Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondria in Human Immunodeficiency Virus Type 1-Infected Children Receiving Highly Active Antiretroviral Therapy. Antimicrob. Agents Chemother. 51: 4236-4242 [Abstract] [Full Text]  
  • Lund, K. C., Peterson, L. L., Wallace, K. B. (2007). Absence of a Universal Mechanism of Mitochondrial Toxicity by Nucleoside Analogs. Antimicrob. Agents Chemother. 51: 2531-2539 [Abstract] [Full Text]  
  • Gu, Z., Allard, B., de Muys, J. M., Lippens, J., Rando, R. F., Nguyen-Ba, N., Ren, C., McKenna, P., Taylor, D. L., Bethell, R. C. (2006). In Vitro Antiretroviral Activity and In Vitro Toxicity Profile of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor for Treatment of Human Immunodeficiency Virus Infection. Antimicrob. Agents Chemother. 50: 625-631 [Abstract] [Full Text]  
  • Milazzo, L., Piazza, M., Sangaletti, O., Gatti, N., Cappelletti, A., Adorni, F., Antinori, S., Galli, M., Moroni, M., Riva, A. (2005). [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother 55: 84-89 [Abstract] [Full Text]  
  • Note, R., Maisonneuve, C., Letteron, P., Peytavin, G., Djouadi, F., Igoudjil, A., Guimont, M.-C., Biour, M., Pessayre, D., Fromenty, B. (2003). Mitochondrial and Metabolic Effects of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in Mice Receiving One of Five Single- and Three Dual-NRTI Treatments. Antimicrob. Agents Chemother. 47: 3384-3392 [Abstract] [Full Text]  
  • Marceau, G., Sapin, V., Jacomet, C., Ughetto, S., Cormerais, L., Regagnon, C., Dastugue, B., Peigue-Lafeuille, H., Beytout, J., Laurichesse, H. (2003). Frequency, Risk Factors, and Outcome of Hyperlactatemia in HIV-positive Persons: Implications for the Management of Treated Patients. Clin. Chem. 49: 1154-1162 [Abstract] [Full Text]  
  • Tolomeo, M, Mancuso, S, Todaro, M, Stassi, G, Catalano, M, Arista, S, Cannizzo, G, Barbusca, E, Abbadessa, V (2003). Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy. J. Clin. Pathol. 56: 147-151 [Abstract] [Full Text]  
  • Stuyver, L. J., Lostia, S., Adams, M., Mathew, J. S., Pai, B. S., Grier, J., Tharnish, P. M., Choi, Y., Chong, Y., Choo, H., Chu, C. K., Otto, M. J., Schinazi, R. F. (2002). Antiviral Activities and Cellular Toxicities of Modified 2',3'-Dideoxy-2',3'-Didehydrocytidine Analogues. Antimicrob. Agents Chemother. 46: 3854-3860 [Abstract] [Full Text]  
  • Cote, H. C.F., Brumme, Z. L., Craib, K. J.P., Alexander, C. S., Wynhoven, B., Ting, L., Wong, H., Harris, M., Harrigan, P. R., O'Shaughnessy, M. V., Montaner, J. S.G. (2002). Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients. NEJM 346: 811-820 [Abstract] [Full Text]  
  • Birkus, G., Hitchcock, M. J. M., Cihlar, T. (2002). Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors. Antimicrob. Agents Chemother. 46: 716-723 [Abstract] [Full Text]  
  • Szewczyk, A., Wojtczak, L. (2002). Mitochondria as a Pharmacological Target. Pharmacol. Rev. 54: 101-127 [Abstract] [Full Text]  
  • Gaou, I., Malliti, M., Guimont, M.-C., Lettéron, P., Demeilliers, C., Peytavin, G., Degott, C., Pessayre, D., Fromenty, B. (2001). Effect of Stavudine on Mitochondrial Genome and Fatty Acid Oxidation in Lean and Obese Mice. J. Pharmacol. Exp. Ther. 297: 516-523 [Abstract] [Full Text]  
  • Bryant, M. L., Bridges, E. G., Placidi, L., Faraj, A., Loi, A.-G., Pierra, C., Dukhan, D., Gosselin, G., Imbach, J.-L., Hernandez, B., Juodawlkis, A., Tennant, B., Korba, B., Cote, P., Marion, P., Cretton-Scott, E., Schinazi, R. F., Sommadossi, J.-P. (2001). Antiviral L-Nucleosides Specific for Hepatitis B Virus Infection. Antimicrob. Agents Chemother. 45: 229-235 [Abstract] [Full Text]  
  • Bonnet, E., Ruidavets, J.-B., Tuech, J., FerriÈres, J., Collet, X., Fauvel, J., Massip, P., Perret, B. (2001). Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy. J. Clin. Endocrinol. Metab. 86: 296-302 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»